We are international
Donate
• health professionals TEXT SIZE   


KOS 2007: The Treatment of Relapsed and Refractory Myeloma: Focus on Bortezomib and Bortezomib-based Combinations
Paul Richardson, MD
Medical Oncology
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA, USA
06.27.07
Back



To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles